Riga, November 1, 2024 – We are pleased to announce a new clinical study in collaboration with the international team at the MINST Institute in Riga, aimed specifically at supporting individuals with disabilities, including wheelchair users and prosthetic wearers. This study will explore innovative therapeutic approaches to enhance joint health and reduce chronic inflammation resulting from limited mobility and excessive joint strain.
This two-phase study first examines a specially formulated dietary supplement containing natural ingredients designed to support joint function and reduce inflammation. The supplement includes collagen hydrolysate, hyaluronic acid, and anti-inflammatory plant extracts such as Boswellia Serrata.
In the second phase, Hyperbaric Oxygen Therapy (HBOT) will be tested as a complementary treatment. HBOT is an established therapy where patients breathe pure oxygen in a pressurized chamber, which promotes tissue regeneration, reduces inflammation, and supports wound healing—a particularly relevant benefit for prosthetic wearers.
People with disabilities often face chronic pain and restricted mobility due to joint overuse. This pioneering study aims to achieve long-term improvements in joint health and an enhanced quality of life through a combination of dietary supplementation and HBOT.
